0
World
Celltrion posts record Q1 earnings on strong biosimilar sales
May 6, 2026
Scroll
Posted 1 hour ago by
Celltrion said Wednesday it posted record first-quarter results, with consolidated revenue of over 1.14 trillion won (783 million) and operating profit of 321.9 billion won. Revenue rose 36 percent on-year, while operating profit surged 115.5 percent, with the operating margin improving to 28.1 percent. All 11 biosimilar products currently on the market maintained stable revenue streams, while high-margin new products drove growth, with sales from the segment jumping 67 percent on-year.
These n
The korea Herald News
Coverage and analysis from South Korea. All insights are generated by our AI narrative analysis engine.
South Korea
Bias: center
People's Voices (0)
Leave a comment
0/500
Note: Comments are moderated. Please keep it civil. Max 3 comments per day.